MedCrypt regularly talks about security in medical devices, from pacemakers to surgical robots. The exponential growth of connected devices in healthcare combined with the FDA mandate to “bake in” security into devices means the best solution is one that secures devices, not the hospital network.
FDA says manufacturers and hospitals are both responsible for protecting devices from growing cybersecurity threats. However, experts say healthcare providers carry a much heavier load.
The AbedGraham Group and MedCrypt have partnered together to offer a more comprehensive and meaningful analysis of the cyber risk exposure of medical devices. Leveraging our collective expertise in medical device security and clinical risk management, we will contrast and compare different risk scoring approaches based on a single device as well as a device in its integrated environment.
In this webinar recording, Seth Carmody (MedCrypt, frm FDA) and Kyle Erickson (Senior Director for CRM Product Security at MDT) discuss the business case for SBOMs, challenges faced, and potential ways to succeed.
Since 2017, we’ve released an annual white paper analyzing ICS-CERT vulnerability disclosure data, outlining the trends we see, and revealing data-driven predictions for the future of medical device cybersecurity. This webinar discusses our 2021 findings in depth, looking closely at analyzing medical device vulnerability trends, involving security researchers in the disclosure process, and reporting vulnerabilities as a medical device manufacturer.
The reality is that all the promises held in technology advancing healthcare are foundationally reliant on security. Unfortunately, not only does the healthcare supply chain inherit what makes information security hard, healthcare additionally inherits economic constraints that allow security debt. This webinar discusses security economics in healthcare.
FDA released the Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions updated draft guidance in April 2022. For a deep dive, practical considerations and insight into the draft guidance, MedCrypt's VP Regulatory Strategy and former FDA cybersecurity program manager, Seth Carmody, provides an expert analysis of the document in this webinar.
We started MedCrypt in 2016 to ensure that the medical devices we and our loved ones rely on were as safe and secure as technologically possible. We're not just another cybersecurity company looking to capitalize on the healthcare industry. We are a team of medical device experts who are laser focused on bringing modern cybersecurity features to the next generation of healthcare technology.